Understanding how Epstein-Barr Virus affects Multiple Sclerosis
Official title: Defining the Role of Epstein-Barr Virus in Multiple Sclerosis
Funded at Stanford University · NIH-11062472 · Data updated 2026-11-12
This study is looking at how the Epstein-Barr Virus might be linked to Multiple Sclerosis, and it’s for people with MS who want to help us understand how this virus could affect their condition and treatment by sharing their samples and information.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $192,996 |
| NIH project number | 5K23AI177932-02 |
| Project ID | NIH-11062472 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Multiple Sclerosis, particularly those who have a history of Epstein-Barr Virus infection.
✕Less likely to help
Patients who do not have Multiple Sclerosis or have not been infected with Epstein-Barr Virus may not benefit from this research.
What this research studies
This research investigates the connection between Epstein-Barr Virus (EBV) infection and the development of Multiple Sclerosis (MS), a condition that causes significant disability in young adults. The study will analyze the presence and levels of antibodies against various EBV proteins in large patient groups to understand their role in MS progression and treatment response. By exploring molecular mimicry between EBV and specific proteins in the nervous system, the research aims to uncover critical mechanisms that may contribute to MS. Patients will be involved in providing samples and data to help clarify these relationships.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the causes of Multiple Sclerosis and potentially improve treatment strategies for patients.
How similar studies have gone: Previous research has indicated a potential link between Epstein-Barr Virus and Multiple Sclerosis, suggesting that this approach may yield valuable insights.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Sattarnezhad Oskouei, Neda — Stanford University
- Study coordinator: Sattarnezhad Oskouei, Neda
Related research
Other NIH-funded projects on the same topics.
-
Susceptibility-based MRI biomarkers for multiple sclerosis
A short-term study aims to test MRI biomarkers that could help diagnose and predict MS in patients, using advanced imaging techniques.
-
Mediterranean-style eating and aging in people with multiple sclerosis
This project looks at whether following a Mediterranean-style diet is linked to slower biological aging and less brain shrinkage in people living with multiple sclerosis.
-
Imaging brain energy use in multiple sclerosis with a new imaging method
A new MRI-based method will non-invasively measure how the brain uses glucose and ketones in people with multiple sclerosis.
-
Astrocyte exosomes as aging biomarkers and drivers of MS progression
Researchers are testing a blood-based biomarker from astrocyte-like exosomes to understand why multiple sclerosis gets worse with age and to identify potential targets for treatment.
-
Promoting brain repair in MS with a natural compound that nudges neural stem cells
A researcher is testing a natural-product–based compound that may help people with multiple sclerosis repair nerve damage by guiding brain stem cells to become neurons and myelin-producing cells.
-
Targeted B cell tolerance therapy for multiple sclerosis using Ace-DEX microparticles
A new therapy using tiny biopolymer particles given through the vein aims to retrain B cells to tolerate the immune system in people with multiple sclerosis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.